Administration of Donor T Cells With the Caspase-9 Suicide Gene

Clinical trial NCT01494103 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT01494103
Sponsor: Baylor College of Medicine
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia Myelodysplastic Syndrome Acute Myeloid Leukemia Chronic Myelogenous Leukemia Non Hodgkin Lymphoma Hemophagocytic Lymphohistiocytosis Familial Hemophagocytic Lymphohistiocytosis Hemophagocytic Syndrome Epstein Barr Virus Infection X-linked Lymphoproliferative Disease

Start date: 2011-11-01
Primary completion: 2029-05-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.